Dear Network,
We started a rearch project called ARCHE.
The primary objective of this ARCHE project is to assess the predictive value of the personalized immunogram (https://goo.gl/aFh8fB) in a prospective setting.
We are looking to enroll patients which are relapsing under a non-immunotherapy treatment and that are due to be treated with an anti PD1/PD-L1 therapy as standard of care.
Patient will be tested for 75 genes , PD-L1 expression, and CD8 expression.
We are now looking for specialized oncologist/centers in hepatocellular carcinoma or gastric cancer.
Feel free to tell me if you are interested to know more about one of those projects. We would like to have 1 or 2 partner(s) per cancer type (recruitment to be completed by Q2 2018).
Looking forward to your feedback,